Streptococcus sanguis-induced platelet activation involves two waves of tyrosine phosphorylation mediated by FcγRIIA and α IIbβ3

Thrombosis and Haemostasis

Volumn 93, Issue 5, 2005, Pages 932-939

  Pampolina, Caroline ^a   McNicol, Archibald ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Fc RIIA; PECAM I; Platelet; SHP I; Streptococcus sanguis

Indexed keywords

ACETYLSALICYLIC ACID; ARGINYLGLYCYLASPARTYLSERINE; CD31 ANTIGEN; FC RECEPTOR; FIBRINOGEN RECEPTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN RECEPTOR; LAT PROTEIN; PHOSPHOLIPASE C GAMMA; PHOSPHOLIPASE C GAMMA2; PROTEIN KINASE SYK; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SHP 1; PROTEIN TYROSINE PHOSPHATASE SHP 2; SEROTONIN; THROMBOXANE A2; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUTH FLORA; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DEPHOSPHORYLATION; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; RECEPTOR AFFINITY; SECOND MESSENGER; SIGNAL TRANSDUCTION; STREPTOCOCCUS SANGUINIS; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIGENS, CD; ANTIGENS, CD31; ASPIRIN; BLOOD PLATELETS; CROSS-LINKING REAGENTS; ENZYME PRECURSORS; HUMANS; IMMUNOGLOBULIN G; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; PHOSPHATIDIC ACIDS; PHOSPHOLIPASE C; PHOSPHOLIPASE C GAMMA; PHOSPHOPROTEINS; PHOSPHORYLATION; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROTEIN-TYROSINE KINASES; RECEPTORS, IGG; SEROTONIN; SIGNAL TRANSDUCTION; STREPTOCOCCUS SANGUIS; THROMBOXANE B2; TYROSINE;

EID: 18844444812     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-08-0482     Document Type: Article

References (68)

1. Mattila KJ, Nieminen MS, Valtonen VV, et al. Association between dental health and acute myocardial infarction. Br Med J 1989; 298: 779-82.
2. Beck J, Garcia R, Heiss G, et al. Periodontal disease and cardiovascular disease. J Periodontol 1996; 67: 1123-37.
3. Morrison HI, Ellison LF, Taylor GW. Periodontal disease and risk of fatal coronary heart and cerebrovascular diseases. J Cardiovasc Risk 1999; 6: 7-11.
4. Lusis AJ. Atherosclerosis. Nature 2000; 407: 233-41.
5. Gupta S, Camm AJ. Is there an infective aetiology to atherosclerosis? Drugs Aging 1998; 13: 1-7.
6. Danesh J. Is there a link between chronic Helicobacter pylori infection and coronary heart disease? Eur J Surg Suppl 1998; 582: 27-31.
7. Griffiths PD, Hannington G, Booth JC. Coxsackie B virus infections and myocardial infarction. Results from a prospective, epidemiologically controlled study. Lancet 1980; 1: 1387-9.
8. Herzberg MC, Brintzenhofe KL, Clawson CC. Aggregation of human platelets and adhesion of Streptococcus sanguis. Infect Immun 1983; 39: 1457-69.
9. Sullam PM, Valone FH, Mills J. Mechanisms of platelet aggregation by viridans group streptococci. Infect Immun 1987; 55: 1743-50.
10. Ford I, Douglas CWI, Preston FE, et al. Mechanisms of platelet aggregation by Streptococcus sanguis, a causative organism in infective endocarditis. Br J Haematol 1993; 84: 95-100.
11. Herzberg MC, Meyer MW. Effects of oral flora on platelets: possible consequences in cardiovascular disease. J Periodontol 1996; 67: 1138-42.
12. Herzberg MC, Meyer MW. Dental plaque, platelets, and cardiovascular diseases. Ann Periodontol 1998; 3: 151-60.
13. Meyer MW, Gong K, Herzberg MC. Streptococcus sanguis-induced platelet clotting in rabbits and hemodynamic and cardiopulmonary consequences. Infect Immun 1998; 66: 5906-14.
14. Soberay AH, Herzberg MC, Rudney JD, et al. Responses of platelets to strains of Streptococcus sanguis: findings in healthy subjects, Bernard-Soulier, Glanzmann's, and collagen-unresponsive patients. Thromb Haemost 1987; 57: 222-5.
15. Douglas CW, Brown PR, Preston FE. Platelet aggregation by oral streptococci. FEMS Micrbiol Lett 1990; 60: 63-7.
16. Kerrigan SW, Douglas I, Wray A, et al. A role for glycoprotein Ib in Streptococcus sanguis-induced platelet aggregation. Blood 2002; 100: 509-16.
17. Ford I, Douglas CW, Heath J, et al. Evidence for the involvement of complement proteins in platelet aggregation by Streptococcus sanguis NCTC 7863. Br J Haematol 1996; 94: 729-39.
18. Ford I, Douglas CW, Cox D, et al. The role of immunoglobulin G and fibrinogen in platelet aggregation by Streptococcus sanguis. Br J Haematol 1997; 97: 737-46.
19. Sjobring U, Ringdahl U, Ruggeri ZM. Induction of platelet thrombi by bacteria and antibodies. Blood 2002; 100: 4470-7.
20. Anderson GP, Anderson CL. Signal transduction by the platelet Fc receptor. Blood 1990; 76: 1165-72.
21. Daëron M. Structural bases of Fc gamma R functions. Annu Rev Immunol 1997; 15: 203-34.
22. Huang M-M, Indik Z, Brass LF, et al. Activation of FcRII induces tyrosine phosphorylation of multiple proteins including FcγRII. J Biol Chem 1992; 267; 5467-73.
23. syk. J Biol Chem 1994; 269: 32435-40.
24. Keely PJ, Parise LV. The α2β1 integrin is a necessary co-receptor for collagen-induced activation of Syk and the subsequent phosphorylation of phospholipase Cγ2 in platelets. J Biol Chem 1996; 271: 26668-76.
25. Yanaga F, Poole A, Asselin J, et al. Syk interacts with tyrosine-phosphorylated proteins in human platelets activated by collagen and cross-linking of the Fc γ-IIA receptor. Biochem J 1995; 311: 471-8.
26. Gratacap M, Payrastre B, Viala C, et al. Phosphatidyl 3,4,5-trisphosphate-dependent stimulation of phospholipase Cγ-2 is an early key event in FcγRIIA-mediated activation of human platelets. J Biol Chem 1998; 273: 24314-21.
27. Watson SP, Reep B, McConnell RT, et al. Collagen stimulates [3H] inositol trisphosphate formation in indomethacin-treated human platelets. Biochem J 1985; 226: 831-7.
28. Gergely J, Pecht I, Sarmay G. Immunoreceptor tyrosine-based inhibition motif-bearing receptors regulate the immunoreceptor tyrosine-based activation motif-induced activation of immune competent cells. Immunol Lett 1999; 68: 3-15.
29. Gibbins JM. The negative regulation of platelet function: extending the role of the ITIM. Trends Cardiovasc Med 2002; 12: 213-9.
30. Patil S, Newman DK, Newman PJ. Platelet endothelial cell adhesion molecule-1 serves as an inhibitory receptor that modulates platelet responses to collagen. Blood 2001; 97: 1727-32.
31. Jones KL, Hughan SC, Dopheide SM, et al. Platelet endothelial cell adhesion molecule-1 is a negative regulator of platelet-collagen interactions. Blood 2001; 98: 1456-63.
32. Cicmil M, Thomas JM, Leduc M, et al. Platelet endothelial cell adhesion molecule-1 signaling inhibits the activation of human platelets. Blood 2002; 99: 137-44.
33. Thai LM, Ashman LK, Harbour SN, et al. Physical proximity and functional interplay of PECAM-1 with the Fc receptor FcγRIIa on the platelet plasma membrane. Blood 2003; 102: 3637-45.
34. McNicol A. Platelet preparation and estimation of functional responses. In: Platelets: A Practical Approach (Watson SP, Authi KS, eds), Oxford: Oxford Univ. Press. 1996; 1-26.
35. Nguyen A, Packham MA, Rand ML. Effects of ethanol on platelet responses associated with adhesion to collagen. Thromb Res 1999; 95: 303-14.
36. Clark EA, Brugge JS. Tyrosine phosphorylation. In: Platelets: A Practical Approach (Watson SP, Authi KS, eds), Oxford: Oxford Univ. Press 1996; 199-215.
37. Cicmil M, Thomas JM, Sage T, et al. Collagen, convulxin, and thrombin stimulate aggregation-independent tyrosine phosphorylation of CD31 in platelets. Evidence for the involvement of Src family kinases. J Biol Chem 2000; 275: 27339-47.
38. Holmsen H, Dangelmaier CA, Rongved S. Tight coupling of thrombin-induced hydrolase secretion and phosphatidate synthesis to receptor occupancy in human platelets. Biochem J 1984: 222: 157-67.
39. Lockhart LK, McNicol A. The phospholipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation. J Pharmacol Exp Therap 1999; 289: 721-8.
40. Karni R, Mizrachi S, Reiss-Sklan E, et al. The pp60 (c-Src) inhibitor PP1 is non-competitive against ATP. FEBS Lett 2003; 537: 47-52.
41. Bodin S, Viala C, Ragab A, et al. A critical role of lipid rafts in the organization of a key FcγRIIa-mediated signaling pathway in human platelets. Thromb Haemost 2003; 89: 318-30.
42. Hua CT, Gamble JR, Vadas MA, et al. Recruitment and activation of SHP-1 protein-tyrosine phosphatase by human platelet endothelial cell adhesion molecule-1 (PECAM-1). Identification of immunoreceptor tyrosine-based inhibitory motif-like binding motifs and substrates. J Biol Chem 1998; 273: 28332-40.
43. Jackson DE, Ward CM, Wang R, et al. The protein-tyrosine phosphatase SHP-2 binds platelet/endothelial cell adhesion molecule-1 (PECAM-1) and forms a distinct signaling complex during platelet aggregation. J Biol Chem 1997; 272: 6986-93.
44. Jackson DE, Kupcho KR, Newman PJ. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of platelet/endothelial cell adhesion molecule-1 (PECAM-1) that are required for the cellular association and activation of the protein-tyrosine phosphatase, SHP-2. J Biol Chem 1997; 272: 24868-75.
45. Kullo IJ, Gau GT, Tajik AJ. Novel risk factors for atherosclerosis. Mayo Clin Proc 2000; 75: 369-80.
46. Fong IW. Emerging relations between infectious diseases and coronary artery disease and atherosclerosis. CMAJ 2000; 163: 49-56.
47. Mealey BL. Influence of periodontal infections on systemic health. Periodontology 2000 1999; 21: 197-209.
48. Kinane DF. Periodontal diseases' contributions to cardiovascular disease: an overview of potential mechanisms. Ann Periodontol 1998; 3: 142-50.
49. Schuster GS. Oral flora and pathogenic organisms. Infect Dis Clin N Am 1999; 13: 757-74.
50. Gong K, Wen DY, Ouyang T, et al. Platelet receptors for the Streptococcus sanguis adhesin and aggregation-associated antigens are distinguished by anti-idiotypical monoclonal antibodies. Infect Immun 1995; 63: 3628-33.
51. Sullam PM, Hyun WC, Szollosi J, et al. Physical proximity and functional interplay of the glycoprotein Ib-IX-V complex and the Fc receptor FcγRIIA on the platelet plasma membrane. J Biol Chem 1998; 273: 5331-6.
52. Ibarrola I, Vossebeld PJ, Homburg CH, et al. Influence of tyrosine phosphorylation on protein interaction with FcγRIIa. Biochim Biophys Acta 1997; 1357: 348-58.
53. Ragab A, Bodin S, Viala C, et al. The tyrosine phosphatase 1B regulates linker for activation of T-cell phosphorylation and platelet aggregation upon FcγRIIA cross-linking. J Biol Chem 2003; 278: 40923-32.
54. Rathore V, Stapleton MA, Hillery CA, et al. PECAM-1 negatively regulates GPIb/V/IX signaling in murine platelets. Blood 2003; 102: 3658-64.
55. Zhang Z, Shen K, Lu W, et al. The role of C-terminal tyrosine phosphorylation in the regulation of SHP-1 explored via expressed protein ligation. J Biol Chem 2002; 278: 4668-74.
56. Xu F, Xu M, Zhao R, et al. Tyrosine phosphatases SHP-1 and SHP-2 are associated with distinct tyrosine-phosphorylated proteins. Exp Cell Res 2002; 272: 75-83.
57. Sagawa K, Kimura T, Swieter M, et al. The protein-tyrosine phosphatase SHP-2 associates with tyrosine-phosphorylated adhesion molecule PECAM-1 (CD31). J Biol Chem 1997; 272: 31086-91.
58. Masuda M, Osawa M, Shigematsu H, et al. Platelet endothelial cell adhesion molecule-1 is a major SH-PTP2 binding protein in vascular endothelial cells. FEBS Lett 1997; 408: 331-6.
59. Zhang J, Somani AK, Siminovitch KA. Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signaling. Semin Immunol 2000; 12: 361-78.
60. Qu CK. The SHP-2 tyrosine phosphatase: signaling mechanisms and biological functions. Cell Res 2000; 10: 279-88.
61. Ganesan LP, Fang H, Marsh CB, et al. The protein-tyrosine phosphatase SHP-1 associates with the phosphorylated immunoreceptor tyrosine-based activation motif of FcγRIIA to modulate signaling events in myeloid cells. J Biol Chem 2003; 278: 35710-7.
62. Frank C, Burkhardt C, Imhof D, et al. Effective dephosphorylation of Src substrates by SHP-1. J Biol Chem 2004; 279: 11375-83.
63. Zhang J, Somani AK, Siminovitch KA. Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signaling. Semin Immunol 2000; 12: 361-78.
64. Pasquet JM, Quek L, Pasquet S, et al. Evidence of a role for SHP-1 in platelet activation by the collagen receptor glycoprotein VI. J Biol Chem 2000; 275: 28526-31.
65. Cramer EM, Berger G, Berndt MC. Platelet α-granule and plasma membrane share two new components: CD9 and PECAM-1. Blood 1994; 84: 1722-30.
66. Erickson PR, Herzberg MC. Purification and partial characterization of a 65-kDa platelet aggregation-associated protein antigen from the surface of Streptococcus sanguis. J Biol Chem 1990; 265: 14080-7.
67. Erickson PR, Herzberg MC. The Streptococcus sanguis platelet aggregation-associated protein. Identification and characterization of the minimal platelet-interactive domain. J Biol Chem 1993; 268: 1646-9.
68. McRedmond JP, Harriott P, Walker B et al. Streptokinase-induced platelet activation involves antistreptokinase antibodies and cleavage of protease-activated receptor-1. Blood 2000; 95:1301-8.